JP2829440B2 - Ｏ▲上６▼―アルキルグアニン―ｄｎａアルキルトランスフェラーゼ減少化活性を有するｏ▲上６▼―ベンジル化グアニン、グアノシンおよび２′―デオキシグアノシン化合物 - Google Patents

Ｏ▲上６▼―アルキルグアニン―ｄｎａアルキルトランスフェラーゼ減少化活性を有するｏ▲上６▼―ベンジル化グアニン、グアノシンおよび２′―デオキシグアノシン化合物

Info

Publication number
JP2829440B2
JP2829440B2 JP3507224A JP50722491A JP2829440B2 JP 2829440 B2 JP2829440 B2 JP 2829440B2 JP 3507224 A JP3507224 A JP 3507224A JP 50722491 A JP50722491 A JP 50722491A JP 2829440 B2 JP2829440 B2 JP 2829440B2
Authority
JP
Japan
Prior art keywords
group
carbon atoms
benzyl
substituted
following formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP3507224A
Other languages
English (en)
Japanese (ja)
Other versions
JPH05504972A (ja
Inventor
カール モッシェル，ロバート
アイリーン ドーラン，マリー
イー． ペッグ，アントニー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/492,468 external-priority patent/US5091430A/en
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of JPH05504972A publication Critical patent/JPH05504972A/ja
Application granted granted Critical
Publication of JP2829440B2 publication Critical patent/JP2829440B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP3507224A 1990-03-13 1991-03-13 Ｏ▲上６▼―アルキルグアニン―ｄｎａアルキルトランスフェラーゼ減少化活性を有するｏ▲上６▼―ベンジル化グアニン、グアノシンおよび２′―デオキシグアノシン化合物 Expired - Lifetime JP2829440B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US492,468 1990-03-13
US07/492,468 US5091430A (en) 1990-03-13 1990-03-13 O6 -substituted guanine compounds and methods for depleting O6 -alkylguanine-DNA alkyltransferase levels
US07/616,913 US5352669A (en) 1990-03-13 1990-11-21 O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing O6 -alkylguanine-DNA alkyltransferase depleting activity
US616,913 1990-11-21

Publications (2)

Publication Number Publication Date
JPH05504972A JPH05504972A (ja) 1993-07-29
JP2829440B2 true JP2829440B2 (ja) 1998-11-25

Family

ID=27050758

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3507224A Expired - Lifetime JP2829440B2 (ja) 1990-03-13 1991-03-13 Ｏ▲上６▼―アルキルグアニン―ｄｎａアルキルトランスフェラーゼ減少化活性を有するｏ▲上６▼―ベンジル化グアニン、グアノシンおよび２′―デオキシグアノシン化合物

Country Status (10)

Country Link
US (1) US5352669A (en, 2012)
EP (1) EP0523100B1 (en, 2012)
JP (1) JP2829440B2 (en, 2012)
AT (1) ATE141925T1 (en, 2012)
CA (1) CA2078129C (en, 2012)
DE (1) DE69121706T2 (en, 2012)
DK (1) DK0523100T3 (en, 2012)
ES (1) ES2091322T3 (en, 2012)
GR (1) GR3021277T3 (en, 2012)
WO (1) WO1991013898A1 (en, 2012)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731304A (en) * 1982-08-23 1998-03-24 Cancer Research Campaign Technology Potentiation of temozolomide in human tumour cells
US5691307A (en) * 1990-03-13 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services O6 -substituted guanine compositions and methods for depleting O6
GB9015914D0 (en) * 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds
ZA94248B (en) * 1993-01-14 1994-07-13 Cancer Res Campaign Tech Potentiation of temozolomide in human tumour cells
RU2154646C2 (ru) * 1993-06-08 2000-08-20 Кэнсер Рисерч Кэмпейн Текнолоджи Лимитед Производные о6-алкилгуанина и фармацевтическая композиция
US6043228A (en) * 1993-06-08 2000-03-28 Cancer Research Campaign Technology Limited O6 -substituted guanine derivatives, a process for their preparation and their use in treating tumor cells
US5929046A (en) * 1994-06-08 1999-07-27 Cancer Research Campaign Technology Limited Pyrimidine and purine derivatives and their use in treating tumour cells
US5525606A (en) 1994-08-01 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines
US5965126A (en) * 1996-03-25 1999-10-12 The Penn State Research Foundation use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents
US6060458A (en) * 1998-02-13 2000-05-09 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxyribonucleotides comprising O6 -benzylguanine and their use
WO2003084957A1 (en) * 2002-04-08 2003-10-16 Sumika Fine Chemicals Co., Ltd. Crystal and solvate of 2-amino-6-benzyloxypurine and production methods thereof
KR20050062588A (ko) * 2002-10-03 2005-06-23 에콜 폴리테크니크 페데랄레 드 로잔 Ｏ6-알킬구아닌-ｄｎａ 알킬트랜스퍼라제용 기질
AU2004313931A1 (en) * 2004-01-06 2005-07-28 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services 2-amino-O4-substituted pteridines and their use as inactivators of O6-alkylguanine-DNA alkyltransferase
US7825096B2 (en) * 2004-09-08 2010-11-02 The United States Of America As Represented By The Department Of Health And Human Services O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs
CN100350975C (zh) * 2005-02-03 2007-11-28 山东蓝金生物工程有限公司 抗癌药物组合物
GB0502573D0 (en) * 2005-02-08 2005-03-16 Topotarget As Therapeutic compounds
CN100526315C (zh) 2005-06-16 2009-08-12 浙江医药股份有限公司新昌制药厂 N2-喹啉或异喹啉取代的嘌呤衍生物及其制备方法和其用途
WO2008137207A2 (en) * 2007-05-02 2008-11-13 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Inactivators of o6-alkylguanine-dna alkyltransferase
CN107098906B (zh) * 2017-05-19 2020-05-05 四川大学 苄基鸟嘌呤衍生物及其有机盐类化合物和药物组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
EP0184473A1 (en) * 1984-10-26 1986-06-11 Merck & Co. Inc. Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives
US4801710A (en) * 1984-10-26 1989-01-31 Merck & Co., Inc. Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives
US5723609A (en) * 1988-03-30 1998-03-03 E. R. Squibb & Sons, Inc. Bis (hydroxymethyl) cyclobutyl purines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ｊ．Ｏｒｇ．Ｃｈｅｍ．５１（２２），ｐ４１８０〜４１８５（１９８６）

Also Published As

Publication number Publication date
GR3021277T3 (en) 1997-01-31
EP0523100A4 (en) 1993-03-17
EP0523100A1 (en) 1993-01-20
CA2078129C (en) 1999-05-04
DE69121706D1 (de) 1996-10-02
EP0523100B1 (en) 1996-08-28
DK0523100T3 (en, 2012) 1997-02-10
CA2078129A1 (en) 1991-09-14
AU646452B2 (en) 1994-02-24
DE69121706T2 (de) 1997-01-23
JPH05504972A (ja) 1993-07-29
WO1991013898A1 (en) 1991-09-19
US5352669A (en) 1994-10-04
AU7582191A (en) 1991-10-10
ES2091322T3 (es) 1996-11-01
ATE141925T1 (de) 1996-09-15

Similar Documents

Publication Publication Date Title
JP2829440B2 (ja) Ｏ▲上６▼―アルキルグアニン―ｄｎａアルキルトランスフェラーゼ減少化活性を有するｏ▲上６▼―ベンジル化グアニン、グアノシンおよび２′―デオキシグアノシン化合物
US5091430A (en) O6 -substituted guanine compounds and methods for depleting O6 -alkylguanine-DNA alkyltransferase levels
JP3179494B2 (ja) プロブコールの可溶性類似体
AU2014224111B2 (en) Positively charged water-soluble prodrugs of 1H-imidazo[4,5-c]quinolin-4-amines and related compounds with very high skin penetration rates
JP2001504437A (ja) 免疫抑制性化合物および方法
JPH11503458A (ja) ウィルスおよび癌の増殖を阻害するためのｎ−ホスホノグリシン誘導体含有医薬組成物
KR20120101153A (ko) 점막염 및 체중 감소의 예방 및 치료를 위한 조성물 및 방법
HUT76338A (en) 8alfa-equilin isomer process for its production and pharmaceutical composition containing it
US6911460B2 (en) Antiviral agents and methods of treating viral infections
US5026726A (en) Gossylic iminolactones and gossylic lactones and their anti-viral activities
CZ300455B6 (cs) Stabilní diester, farmaceutický prostredek jej obsahující a jeho použití
CZ20021433A3 (cs) Proléčivo na bázi 6-methoxy-2-naftyloctové kyseliny
CZ20032095A3 (en) Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs
US4851448A (en) Gem-dihalo-1,8-diamino-4-aza-octanes
Waud et al. Antitumor Activity of Ethyl 5-Amino-1, 2-dihydro-2-methyl-3-phenylpyrido [3, 4-b] pyrazin-7-ylcarbamate 2-Hydroxyethanesulfonate, Hydrate (NSC 370147) against Selected Tumor Systems in Culture and in Mice
EP0220409B1 (en) Gem-dihalo and tetrahalo-1,12-diamino-4,9-diaza-dodecanes
JP2001500104A (ja) 活性酸素種の有害作用の処置および予防
KR100718030B1 (ko) 변형성 관절증 치료제
AU646452C (en) O6-benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing O6-alkylguanine-DNA alkyltransferase depleting activity
JPH05186341A (ja) シスチン尿症治療剤
CS276467B6 (en) Pharmaceutical antiviral preparation
ZA200507497B (en) Therapeutic and/or preventive agent for chronic skin disease
JPH02223514A (ja) ポリアミン酸化物
JP2005503333A (ja) １−ブタン酸誘導体およびその使用
JPH1017530A (ja) アニリン誘導体および細胞傷害防御剤

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080925

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090925

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100925

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110925

Year of fee payment: 13

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110925

Year of fee payment: 13